MTOR and breast carcinoma: Finally, MERIT40 is a downstream effector of the Pi3k/Akt/mTOR pathway that complexes with breast cancer gene, (BRCA)-1 in response to DNA damage to promote DNA repair, chemotherapeutic resistance, and the survival of malignant cells99.